ArticleCardiology2026
Cardiogenic Shock: Outcome Patterns Across the Body Mass Spectrum and Renal Vulnerability.
Article in Cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe relationship between body mass index (BMI) and acute kidney injury (AKI) and mortality in infarction-related cardiogenic shock (CS) remains uncertain. We investigated the association between BMI and renal and short-term clinical outcomes in patients with infarction-related CS.
methodsIn this retrospective single-center cohort study, 369 consecutive patients with infarction-related CS were included. BMI was analyzed as the exposure variable and modeled both continuously and according to World Health Organization categories. AKI within 96 h, defined according to Kidney Disease: Improving Global Outcomes creatinine-based criteria, and in-hospital mortality were the primary outcomes; renal replacement therapy (RRT) was a secondary outcome. Associations were assessed using multivariable logistic regression adjusted for prespecified confounders, including age, sex, diabetes mellitus, chronic kidney disease, and baseline estimated glomerular filtration rate. Nonlinear relationships were explored using restricted cubic spline analyses.
resultsAKI occurred in 158 patients (42.8%). Higher BMI, modeled as a continuous variable, was associated with an increased risk of AKI (adjusted OR 1.34 per 5 kg/m2; 95% CI, 1.06-1.69; p = 0.012). RRT was more frequently required in patients with obesity than in those with normal weight (18.5% vs. 8.6%; p = 0.018). When analyzed categorically, overweight (BMI 25.0-29.9 kg/m2) was associated with lower in-hospital mortality compared with normal weight (adjusted OR 0.66; 95% CI, 0.45-0.95; p = 0.028), whereas obesity was not independently associated with mortality. Nonlinear modeling suggested a U-shaped relationship between BMI and both AKI and in-hospital mortality, with the lowest estimated risk at intermediate BMI levels.
conclusionIn patients with infarction-related CS, BMI was associated with both renal outcomes and in-hospital mortality. Higher BMI was linked to increased renal vulnerability, whereas overweight was associated with lower mortality. These findings should be interpreted cautiously given the observational design and the potential for residual confounding and reverse causation, particularly at lower BMI levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.